Cialis tablets are intended as a treatment option for erectile dysfunction. Credit: Amnaj Khetsamtip / Shutterstock. The US Food and Drug Administration (FDA) has removed the clinical hold on a trial ...

Opella said that the FDA lifted the clinical hold on its actual use trial (AUT), which it has planned to support a potential switch of Cialis tablets from a prescription-only medicine to an over ...

Now, after a review, the FDA’s green light marks a “significant step forward in Opella’s data-driven efforts to switch a PDE-5 inhibitor like Cialis ... the French pharma to hone in ...

The trial is aimed at transitioning Cialis (tadalafil) from a prescription-only medication to an over-the-counter option. With this decision, the actual use trial can now proceed, marking Cialis ...

Opella, Sanofi’s Consumer Healthcare business, announced that the US Food and Drug Administration (FDA) has lifted a clinical hold on its planned actual use trial (AUT) to support the switch of Cialis ...

Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, because that familiar routine of deadlines, online meetings, and the like ...

LONDON, Jan 21 (Reuters) - President Donald Trump is pulling the U.S. out of the World Health Organization, raising concerns about the U.N. agency's ability to fight diseases and respond to ...

The past two years have been punishing for the biotech and pharma space. As Wall Street chased the artificial-intelligence boom, drugmakers were left behind, with pharma stocks trading at a ...

NEW DELHI: India is bracing for possible disruptions to its pharmaceutical industry - where the American market accounts for almost a third of exports - during Donald Trump’s presidency.

Recursion Pharmaceuticals has a flashy drug development platform. It has a lot to prove about whether that platform's use of AI is helpful. Some power players have backed it with significant ...

HOUSTON and CAMBRIDGE, Mass., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (NASDAQ: SLRX), a clinical-stage biopharmaceutical company developing therapies for patients with ...

WEST LAFAYETTE, Ind. — Purdue University, in collaboration with Eli Lilly and Company and Merck & Co. Inc., announced Friday (Jan. 17) the launch of the Young Institute Pharmaceutical Manufacturing ...